INTRODUCTION
have described the properties of U-11555A as an antifertility agent in laboratory animals. As with U-11100A (Duncan, Lyster, Clark & Lednicer, 1963) , it prevents pregnancy when given orally in rats, guinea-pigs and rabbits, but is less potent. Because of the similar actions of these two compounds, believed in the case of antifertility activity to be exerted on the zygote (cf. Nelson, Davidson & Wada, 1963) , interest has centred on the more potent and more stable U-l 1100A. Both have utero trophic activity in rats, both antagonize, to some extent, the uterine weight increase caused by oestradiol, and both are reported as effective as antifertility agents only up to Day 4 of pregnancy in the rat. However, Emmens & Martin (1965) found U-l 1100A to possess marked oestrogenic activity in vaginal smear and tetrazolium tests in mice, although with dose-response lines which turned down again at higher doses in all cases, and attributed its antifertility effects to its oestrogenic potency. The compound was also weakly anti-oestrogenic, but exhibited complex interactions with oestradiol.
Preliminary tests with U-l 1555A showed that it is much less potent an oestrogen than U-11100A, weakly anti-oestrogenic, and with an antifertility action in mice not obviously explicable by oestrogenic activity. Vaginal smear tests in rats and mice were as described by Emmens (1957) (Emmens, 1965) . Since activities reported in the rat by Duncan et al. (1962 Replications, not shown in Table 3 , were of five rats/group of the whole design.
* Not significant.
t An effect due to U-11100A (see Table 3 ), since for U-11100A alone x2L n = 7-8, i><0-01.
DISCUSSION
Despite the chemical similarities of U-11100A and U-11555A, it is difficult to suppose that their biological actions are identical. They differ in dose-response relationships both as oestrogens and anti-oestrogens in the mouse, U-11555A showing no evidence of any self-inhibition as is seen with U-l 1100A. They differ in effectiveness on Days 4 to 6 relative to Days 1 to 3 in the rat, and in the ratio of oestrogenic to antifertility potencies in the mouse (U-11100A about unity, U-11555A of the order of 1:20). In a selected series of steroids in which oestrogenic and anti-oestrogenic properties were separated, antifertility effects of the type under discussion were associated only with oestrogenic activity (Emmens, 1965) , but in a series of nonsteroidal substances, although it was not possible to select for such clear-cut separation of action, the correlation with oestrogenic activity was only partial, and such compounds as mrl 37, l-[j!>-(2-diethylaminoethoxy)phenyl]-2-(j!>-methoxyphenyl)-l-phenylethane, and meso-, meso-a,a'-dimethyl-4,4'-dihydroxybibenzyl, appear to be exceptions, in which oestrogenic activity can hardly be supposed to explain antifertility action. U-11555A would seem to be a further example, in which anti-oestrogenic activity is a possible alternative explanation. Another more recent example is erythro-DMA (Emmens, Collins, Hobbs, Miller & Owen, 1968) , with a much higher level of overall activity, oestrogenic at 15 ¿ug subcutaneously in the mouse, anti-oestrogenic intra¬ vaginally at 0-4/¿g, and antifertility at less than 1 /zg/day on Days 1 to 3 or 4 to 6 of pregnancy.
